• Username (E-mail)
  • Password
Dow 20,822 0.1%  EStoxx50 3,304 -0.9%  Nikkei 19,284 -0.5%  EUR 1.0566 0.0% 
Nasdaq 5,845 0.2%  FTSE100 7,244 -0.4%  Yen 112.1450 0.0%  Oil 56.0 -0.8% 
S&P500 2,367 0.2%  DAX 11,804 -1.2%  GBP 1.2480 0.2%  Gold 1,257 0.0% 

Vertex Pharmaceuticals share [Symbol: VRTX / ISIN: US92532F1003]

Realtimequote Vertex Pharmaceuticals Inc. in USD

Exchange Market
86.02
Last
77,503
Volume
Time 03:59 PM
02/24/2017 03:59:50 PM UTC-0500
activate push

Stock Price Vertex Pharmaceuticals Inc. in USD

Activate push
86.07 USD 0.34 USD 0.40 %
Trade Time 8:10 PM Trade Date 2/24/2017
Daily High 0.00 Open 0.00
Daily Low 0.00 Prev. Close 86.07
52-week High 103.68 Volume (Qty.) 0
52-week Low 71.50 Market Cap (USD) 21.15 B
52-week Perf.
Exchange

Analyst Opinions for Vertex Pharmaceuticals Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
12/14/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
12/05/12
Vertex Pharmaceuticals RBC Capital Markets
11/13/12
Vertex Pharmaceuticals Credit Suisse Group
11/05/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
11/02/12
Vertex Pharmaceuticals UBS AG

Moody's Rating for Vertex Pharmaceuticals Inc.

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating
Rating Update
Date of Rating
Rating Office -

Profile Vertex Pharmaceuticals Inc.

Company Profile
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
pagehit

Add or Edit Instrument

Vertex Pharmaceuticals Chart - 1 Year - NAS
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: NAS
  • Chart Options

Estimates for Vertex Pharmaceuticals

2016 2017e 2018e
Dividend - - -
Dividend Yield in % - - -
P/E Ratio 87.21 57.82 30.14
EPS 0.85 1.56 2.98

Vertex Pharmaceuticals Key Figures

Market Cap (USD) 21.15 B
Free Float in % 99.45
Number of Shares (Mio.) 248.03
Cash Flow per Share 0.78
Book Value per Share 4.52
60-Days Volatility 37.4
P/B Ratio 16.40

Base Data Vertex Pharmaceuticals

Symbol VRTX
ISIN US92532F1003
Indices BX Swiss - USA, NASDAQ Comp., S&P 500, NASDAQ 100

About the Company Vertex Pharmaceuticals

Country USA

Vertex Pharmaceuticals Historical Prices

02/23/2017
02/23/2017 06:00:00 PM UTC-0500
86.07 513,178
02/22/2017
02/22/2017 06:00:00 PM UTC-0500
85.73 393,710
02/21/2017
02/21/2017 06:00:00 PM UTC-0500
85.79 496,493
02/20/2017
02/20/2017 06:00:00 PM UTC-0500
86.55 685,167
02/16/2017
02/16/2017 06:00:00 PM UTC-0500
88.33 583,409

Vertex Pharmaceuticals Peer Group

Abbott Laboratories 45.68
0.6%
AstraZeneca 46.16
0.3%
Bayer 104.55
-0.4%
Bristol-Myers Squibb 56.44
1.2%
GlaxoSmithKline 16.42
0.6%
Merck 66.16
0.5%
Novartis 77.45
-0.3%
Pfizer 34.26
0.6%
Vertex Pharmaceuticals 86.07
0.4%

Similar shares with higher 1-year perf.